Table 3.
Characteristics Associated With Incident Frailty and Cognitive Decline
Frailty |
Cognitive Decline |
|||
---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | |
COVID-19 (yes vs no) | 4.95 (1.13–21.6) | .03 | 1.89 (0.69–5.21) | .22 |
Age ≥80 y (vs <80) | 2.84 (0.73–11.0) | .13 | 2.17 (0.53–8.93) | .28 |
Sex (female vs male) | 4.44 (0.75–26.3) | .10 | 0.63 (0.23–1.69) | .36 |
CIRS-comorbidity index ≥5 (vs <5) | 3.31 (0.93–11.8) | .06 | 1.72 (1.03–7.17) | .04 |
Frailty (vs nonfrailty) | – | – | 2.76 (1.07–7.12) | .03 |
CI, confidence Interval; CIRS, Cumulative Illness Rating Scale; OR, odds ratio.
Characteristics associated with incident frailty and cognitive decline (defined as a reduction in MMSE score >2 points from pre- to post-COVID assessments) were evaluated through logistic regression models. Independent variables included COVID-19, age, sex, CIRS-comorbidity index and, only for cognitive decline, frailty at the pre-COVID assessment.